ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTXNewsfile Corp • 09/02/22
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/02/22
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTXPRNewsWire • 09/01/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTXNewsfile Corp • 08/30/22
Wall Street Analysts Predict a 225% Upside in TG Therapeutics (TGTX): Here's What You Should KnowZacks Investment Research • 08/29/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTXNewsfile Corp • 08/28/22
ROSEN, LEADING INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTXPRNewsWire • 08/26/22
TG Therapeutics Announces Results from the ULTIMATE I & II Phase 3 Trials of Investigational Ublituximab in RMS Published in The New England Journal of MedicineGlobeNewsWire • 08/25/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Securities Class Action FiledNewsfile Corp • 08/24/22
ROSEN, Top Ranked Investor Counsel, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTXNewsfile Corp • 08/20/22
TGTX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Securities Fraud Lawsuit PendingNewsfile Corp • 08/17/22
ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTXNewsfile Corp • 08/16/22
SHAREHOLDER ACTON NOTICE: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/16/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTXPRNewsWire • 08/16/22
SHAREHOLDER ACTON REMINDER: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/15/22
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTXNewsfile Corp • 08/13/22
Can TG Therapeutics (TGTX) Climb 193% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 08/12/22
INVESTOR ACTON NOTICE: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/11/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class ActionNewsfile Corp • 08/10/22
INVESTOR ACTON REMINDER: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/10/22
ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTXNewsfile Corp • 08/09/22
TGTX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving TG Therapeutics, Inc.Newsfile Corp • 08/09/22
INVESTOR ACTON ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 08/09/22
TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/08/22
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial ResultsGlobeNewsWire • 08/08/22